- Home
- VOR vs WEYS Comparison
VOR vs WEYS Comparison
Compare VOR & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- WEYS
- Stock Information
- Founded
- VOR 2015
- WEYS 1906
- Country
- VOR United States
- WEYS United States
- Employees
- VOR N/A
- WEYS N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- WEYS Apparel
- Sector
- VOR Health Care
- WEYS Consumer Staples
- Exchange
- VOR Nasdaq
- WEYS Nasdaq
- Market Cap
- VOR 261.2M
- WEYS 303.5M
- IPO Year
- VOR 2021
- WEYS N/A
- Fundamental
- Price
- VOR $1.99
- WEYS $30.26
- Analyst Decision
- VOR Buy
- WEYS
- Analyst Count
- VOR 7
- WEYS 0
- Target Price
- VOR $3.77
- WEYS N/A
- AVG Volume (30 Days)
- VOR 4.9M
- WEYS 11.2K
- Earning Date
- VOR 08-15-2025
- WEYS 08-05-2025
- Dividend Yield
- VOR N/A
- WEYS 3.60%
- EPS Growth
- VOR N/A
- WEYS N/A
- EPS
- VOR N/A
- WEYS 2.69
- Revenue
- VOR N/A
- WEYS $281,051,000.00
- Revenue This Year
- VOR N/A
- WEYS N/A
- Revenue Next Year
- VOR N/A
- WEYS N/A
- P/E Ratio
- VOR N/A
- WEYS $11.16
- Revenue Growth
- VOR N/A
- WEYS N/A
- 52 Week Low
- VOR $0.13
- WEYS $25.51
- 52 Week High
- VOR $3.29
- WEYS $41.05
- Technical
- Relative Strength Index (RSI)
- VOR 51.36
- WEYS 45.76
- Support Level
- VOR $2.02
- WEYS $28.00
- Resistance Level
- VOR $2.14
- WEYS $30.08
- Average True Range (ATR)
- VOR 0.19
- WEYS 1.00
- MACD
- VOR -0.08
- WEYS -0.09
- Stochastic Oscillator
- VOR 16.46
- WEYS 42.72
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.